Target intelligence / Profile preview

28S ribosomal RNA sarcin-ricin loop (SRL)

Target
SRL
Molecular classification
Other
01

Overview

The 28S ribosomal RNA sarcin-ricin loop (SRL) is a highly conserved 12-nucleotide sequence in the large ribosomal subunit that is critical for protein synthesis (Endo & Tsurugi, 1987). It serves as the primary binding site for translational GTPases, such as elongation factors eEF-1 and eEF-2, which facilitate the movement of mRNA and tRNA through the ribosome (Shi et al., 2012). The SRL is the specific molecular target for Ribosome-Inactivating Proteins (RIPs), most notably the ricin A-chain (RTA) and Shiga toxins (Stx). These toxins function as RNA N-glycosidases that specifically depurinate the adenine residue at position A4324 in humans (Grela et al., 2019). This single modification prevents the binding of elongation factors, leading to a complete arrest of protein translation and subsequent cell death via apoptosis (Stirpe, 2004). Because of its essentiality and the extreme potency of the toxins that target it, the SRL is a major focus in toxicology and biodefense research. Additionally, the SRL-targeting mechanism is exploited in the development of immunotoxins, where RIPs are conjugated to antibodies for targeted cancer therapy (Walsh et al., 2013).

Other names
Sarcin-ricin loopSRLAlpha-sarcin loop28S rRNA adenine 4324Ricin-sarcin loop
02

Mechanism of action

N-glycosidase-mediated depurination of adenine A4324, which prevents the binding of elongation factors to the ribosome.

03

Biological functions

Cell deathOther
04

Disease associations

InfectionCancerOther
05

Safety considerations

Extreme toxicityIrreversible ribosome damageLack of specific clinical antidotes
06

Interacting drugs

Ricin

4 more in the full profile.

07

Biomarkers

Depurinated 28S rRNAInhibition of protein synthesis

Beyond the preview

Go deeper on 28S ribosomal RNA sarcin-ricin loop (SRL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 28S ribosomal RNA sarcin-ricin loop (SRL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call